Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines

Maria Cristina Honorati, Erminia Mariani, Paolo Dolzani, Andrea Facchini, R. Ansaloni, L. Bonazzi, A. Giamperoli, G. Guerra, M. Martuzzi, M. Monti, M. C. Pirazzini, M. Tangenti, M. Baraldini, C. A. Busachi, M. Capelli, R. Da Re, G. Finzi, F. Giorgetti, M. Magnani, R. MinieroE. Pisi, G. Sprovien, U. Volta, M. Zanetti, G. Giuliani Piccari, A. Accogli, A. M. Borrelli, P. Cacciari, A. Pizzoferrato, A. Ragazzi, G. Risi

Research output: Contribution to journalArticle

Abstract

Personnel (1856 subjects) belonging to local health units (medical and paramedical staff) that have been vaccinated since 1984 against hepatitis B virus (HBV) with HBsAg plasma purified preparations (Hevac-B and H-B-Vax) or recombinant DNA preparation (Engerix-B) were followed in plasma anti-HBs antibody levels. At the end of the protocols, different seroconversion percentages and different anti-HBs levels were reached: the best results were obtained with Engerix-B. Sex and principally age influenced the antibody production: women generally reached highest protective antibody levels and the 21-30 year group was more responsive than other groups. The injection of a supplementary 4th or 5th dose in low or non-responders could restore the specific immunity in the majority of the subjects and increase the anti-HBs level. The time course after the immunization of antibody levels depended on the level reached at the end of vaccination schedule. These data suggest that different antibody level monitorings of vaccinated subjects, planned on the basis of the antibody level reached at the end of vaccination, could prvent a loss of protection against the HBV infection.

Original languageEnglish
Pages (from-to)369-374
Number of pages6
JournalAnnali dell'Istituto Superiore di Sanita
Volume32
Issue number3
Publication statusPublished - 1996

Fingerprint

Hepatitis B Vaccines
Synthetic Vaccines
Antibodies
Hepatitis B virus
Vaccination
Recombinant DNA
Medical Staff
Virus Diseases
Hepatitis B Surface Antigens
Antibody Formation
Anti-Idiotypic Antibodies
Immunity
Immunization
Appointments and Schedules
Injections
Health
Engerix-B

Keywords

  • antibodies
  • hepatitis B
  • vaccine schedule

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines. / Honorati, Maria Cristina; Mariani, Erminia; Dolzani, Paolo; Facchini, Andrea; Ansaloni, R.; Bonazzi, L.; Giamperoli, A.; Guerra, G.; Martuzzi, M.; Monti, M.; Pirazzini, M. C.; Tangenti, M.; Baraldini, M.; Busachi, C. A.; Capelli, M.; Da Re, R.; Finzi, G.; Giorgetti, F.; Magnani, M.; Miniero, R.; Pisi, E.; Sprovien, G.; Volta, U.; Zanetti, M.; Giuliani Piccari, G.; Accogli, A.; Borrelli, A. M.; Cacciari, P.; Pizzoferrato, A.; Ragazzi, A.; Risi, G.

In: Annali dell'Istituto Superiore di Sanita, Vol. 32, No. 3, 1996, p. 369-374.

Research output: Contribution to journalArticle

Honorati, MC, Mariani, E, Dolzani, P, Facchini, A, Ansaloni, R, Bonazzi, L, Giamperoli, A, Guerra, G, Martuzzi, M, Monti, M, Pirazzini, MC, Tangenti, M, Baraldini, M, Busachi, CA, Capelli, M, Da Re, R, Finzi, G, Giorgetti, F, Magnani, M, Miniero, R, Pisi, E, Sprovien, G, Volta, U, Zanetti, M, Giuliani Piccari, G, Accogli, A, Borrelli, AM, Cacciari, P, Pizzoferrato, A, Ragazzi, A & Risi, G 1996, 'Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines', Annali dell'Istituto Superiore di Sanita, vol. 32, no. 3, pp. 369-374.
Honorati, Maria Cristina ; Mariani, Erminia ; Dolzani, Paolo ; Facchini, Andrea ; Ansaloni, R. ; Bonazzi, L. ; Giamperoli, A. ; Guerra, G. ; Martuzzi, M. ; Monti, M. ; Pirazzini, M. C. ; Tangenti, M. ; Baraldini, M. ; Busachi, C. A. ; Capelli, M. ; Da Re, R. ; Finzi, G. ; Giorgetti, F. ; Magnani, M. ; Miniero, R. ; Pisi, E. ; Sprovien, G. ; Volta, U. ; Zanetti, M. ; Giuliani Piccari, G. ; Accogli, A. ; Borrelli, A. M. ; Cacciari, P. ; Pizzoferrato, A. ; Ragazzi, A. ; Risi, G. / Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines. In: Annali dell'Istituto Superiore di Sanita. 1996 ; Vol. 32, No. 3. pp. 369-374.
@article{3e24a771370c496ab551bc0160d697ac,
title = "Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines",
abstract = "Personnel (1856 subjects) belonging to local health units (medical and paramedical staff) that have been vaccinated since 1984 against hepatitis B virus (HBV) with HBsAg plasma purified preparations (Hevac-B and H-B-Vax) or recombinant DNA preparation (Engerix-B) were followed in plasma anti-HBs antibody levels. At the end of the protocols, different seroconversion percentages and different anti-HBs levels were reached: the best results were obtained with Engerix-B. Sex and principally age influenced the antibody production: women generally reached highest protective antibody levels and the 21-30 year group was more responsive than other groups. The injection of a supplementary 4th or 5th dose in low or non-responders could restore the specific immunity in the majority of the subjects and increase the anti-HBs level. The time course after the immunization of antibody levels depended on the level reached at the end of vaccination schedule. These data suggest that different antibody level monitorings of vaccinated subjects, planned on the basis of the antibody level reached at the end of vaccination, could prvent a loss of protection against the HBV infection.",
keywords = "antibodies, hepatitis B, vaccine schedule",
author = "Honorati, {Maria Cristina} and Erminia Mariani and Paolo Dolzani and Andrea Facchini and R. Ansaloni and L. Bonazzi and A. Giamperoli and G. Guerra and M. Martuzzi and M. Monti and Pirazzini, {M. C.} and M. Tangenti and M. Baraldini and Busachi, {C. A.} and M. Capelli and {Da Re}, R. and G. Finzi and F. Giorgetti and M. Magnani and R. Miniero and E. Pisi and G. Sprovien and U. Volta and M. Zanetti and {Giuliani Piccari}, G. and A. Accogli and Borrelli, {A. M.} and P. Cacciari and A. Pizzoferrato and A. Ragazzi and G. Risi",
year = "1996",
language = "English",
volume = "32",
pages = "369--374",
journal = "Annali dell'Istituto Superiore di Sanita",
issn = "0021-2571",
publisher = "Istituto Superiore di Sanita",
number = "3",

}

TY - JOUR

T1 - Biological parameters influencing the immunological response to plasma derived and recombinant hepatitis B vaccines

AU - Honorati, Maria Cristina

AU - Mariani, Erminia

AU - Dolzani, Paolo

AU - Facchini, Andrea

AU - Ansaloni, R.

AU - Bonazzi, L.

AU - Giamperoli, A.

AU - Guerra, G.

AU - Martuzzi, M.

AU - Monti, M.

AU - Pirazzini, M. C.

AU - Tangenti, M.

AU - Baraldini, M.

AU - Busachi, C. A.

AU - Capelli, M.

AU - Da Re, R.

AU - Finzi, G.

AU - Giorgetti, F.

AU - Magnani, M.

AU - Miniero, R.

AU - Pisi, E.

AU - Sprovien, G.

AU - Volta, U.

AU - Zanetti, M.

AU - Giuliani Piccari, G.

AU - Accogli, A.

AU - Borrelli, A. M.

AU - Cacciari, P.

AU - Pizzoferrato, A.

AU - Ragazzi, A.

AU - Risi, G.

PY - 1996

Y1 - 1996

N2 - Personnel (1856 subjects) belonging to local health units (medical and paramedical staff) that have been vaccinated since 1984 against hepatitis B virus (HBV) with HBsAg plasma purified preparations (Hevac-B and H-B-Vax) or recombinant DNA preparation (Engerix-B) were followed in plasma anti-HBs antibody levels. At the end of the protocols, different seroconversion percentages and different anti-HBs levels were reached: the best results were obtained with Engerix-B. Sex and principally age influenced the antibody production: women generally reached highest protective antibody levels and the 21-30 year group was more responsive than other groups. The injection of a supplementary 4th or 5th dose in low or non-responders could restore the specific immunity in the majority of the subjects and increase the anti-HBs level. The time course after the immunization of antibody levels depended on the level reached at the end of vaccination schedule. These data suggest that different antibody level monitorings of vaccinated subjects, planned on the basis of the antibody level reached at the end of vaccination, could prvent a loss of protection against the HBV infection.

AB - Personnel (1856 subjects) belonging to local health units (medical and paramedical staff) that have been vaccinated since 1984 against hepatitis B virus (HBV) with HBsAg plasma purified preparations (Hevac-B and H-B-Vax) or recombinant DNA preparation (Engerix-B) were followed in plasma anti-HBs antibody levels. At the end of the protocols, different seroconversion percentages and different anti-HBs levels were reached: the best results were obtained with Engerix-B. Sex and principally age influenced the antibody production: women generally reached highest protective antibody levels and the 21-30 year group was more responsive than other groups. The injection of a supplementary 4th or 5th dose in low or non-responders could restore the specific immunity in the majority of the subjects and increase the anti-HBs level. The time course after the immunization of antibody levels depended on the level reached at the end of vaccination schedule. These data suggest that different antibody level monitorings of vaccinated subjects, planned on the basis of the antibody level reached at the end of vaccination, could prvent a loss of protection against the HBV infection.

KW - antibodies

KW - hepatitis B

KW - vaccine schedule

UR - http://www.scopus.com/inward/record.url?scp=12644256602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644256602&partnerID=8YFLogxK

M3 - Article

C2 - 9028059

AN - SCOPUS:12644256602

VL - 32

SP - 369

EP - 374

JO - Annali dell'Istituto Superiore di Sanita

JF - Annali dell'Istituto Superiore di Sanita

SN - 0021-2571

IS - 3

ER -